Evidence map›Paper›PMID 41222306›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Design of a Trigger-Responsive Photothermal Vesicle-Based Cargo Delivery Platform.

Anastassiya Schramm, Nina F Conzelmann, Ann-Kathrin Gelmroth, Julia Köberle, Stefan Schramm, Rumiana Dimova, Ilia Platzman, Joachim Spatz

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anastassiya SchrammDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0009-0004-2439-9228
Nina F ConzelmannDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0009-0000-8573-8546
Ann-Kathrin GelmrothDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Julia KöberleDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.
Stefan SchrammOrganic Chemistry, University of Applied Sciences Dresden, Friedrich-List-Platz 1, 01069, Dresden, Germany.ORCID 0000-0002-6109-0893
Rumiana DimovaMax Planck Institute of Colloids and Interfaces, Science Park Golm, 14476, Potsdam, Germany.ORCID 0000-0002-3872-8502
Ilia PlatzmanDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0000-0003-1239-7458
Joachim SpatzDepartment of Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0000-0003-3419-9807

Funding

Bundesministerium für Bildung und ForschungDeutsche ForschungsgemeinschaftDieter Schwarz FoundationExcellence Strategy of Heidelberg University ExU 6.1.11Germany's Excellence Strategy via the Excellence Cluster 3D Matter Made to Order EXC-2082/1-390761711Gottfried Wilhelm Leibniz AwardMax-Planck-Gesellschaft
6 · The paper itself

Abstract

Cargo delivery systems enable the targeted transport of therapeutic agents to specific sites, enhancing treatment efficacy while minimizing systemic side effects. However, many existing systems struggle with achieving precise control over the release timing. Here, a photothermal trigger-responsive delivery platform based on Giant Unilamellar Vesicles (GUVs) functionalized with gold nanorods (GNRs) is described to overcome these challenges. Toward this end, cargo-loaded GUVs are produced using the emulsion transfer method and effective GNR attachment to the vesicle membrane is achieved by functionalizing the GNRs with cholesterol. The near-infrared light (NIR)-mediated cargo release mechanism is described. Importantly, high release efficiency is achieved by optimizing the cholesterol concentration on the GNRs, which is essential for controlling the GNR attachment mechanism to the GUV membrane. Finally, GNR-functionalized ampicillin-loaded GUVs are tested in the presence of E. coli bacteria to demonstrate the platform's functionality. Following NIR-triggered antibiotic release, bacterial growth is inhibited. This showcases the practical potential of the developed trigger-responsive system. Notably, GNR-mediated photothermal heating alone also reduces bacterial viability upon extended illumination, indicating a dual antibacterial mechanism. This versatile and biocompatible system offers a controlled delivery method with broad applicability for therapeutics, diagnostics, and other biomedical applications.

Indexed as

Drug Delivery SystemsUnilamellar LiposomesAnti-Bacterial AgentsEscherichia coliGoldInfrared RaysNanotubesAnti-Bacterial AgentsGoldUnilamellar Liposomesdrug deliverygold nanorodsGUVstrigger‐responsive materials

Identifiers

PMID41222306
PMCPMC12723353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.